Visipaque 320

peripheral venography, excretory urography, peripheral arteriography + 6 more

Treatment

0 Active Studies for Visipaque 320

What is Visipaque 320

Iodixanol

The Generic name of this drug

Treatment Summary

Iodixanol is a type of medicine that helps make blood vessels and organs more visible on medical scans. It is often used during coronary angiography, especially in people with kidney problems, since it is believed to be less harmful to the kidneys than other contrast agents.

Visipaque

is the brand name

Visipaque 320 Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Visipaque

Iodixanol

2002

4

Effectiveness

How Visipaque 320 Affects Patients

Iodixanol is a special type of dye used during coronary angiography, especially for people with kidney issues. It is considered to be safer for the kidneys than other dyes used during this procedure. Its osmolality (a measure of concentration) is the same as blood.

How Visipaque 320 works in the body

Organic iodine compounds absorb x-rays, so that structures containing iodine are more visible on an x-ray image. When injected into the bloodstream, iodixanol will make the inside of the body more visible on an x-ray. This effect lasts until the compound is diluted and eliminated from the body.

When to interrupt dosage

The proposed dosage of Visipaque 320 is contingent upon the determined disorder, including left ventriculography, Arteriography and peripheral arteriography. The amount of dosage is contingent upon the method of administration (e.g. Intravascular or Solution - Intra-arterial; Intravenous), outlined in the table underneath.

Condition

Dosage

Administration

peripheral arteriography

, 320.0 mg/mL, 270.0 mg/mL, 652.0 mg/mL, 550.0 mg/mL

, Intra-arterial; Intravenous, Solution, Solution - Intra-arterial; Intravenous, Intravascular, Injection, solution, Injection, solution - Intravascular

Arteriography

, 320.0 mg/mL, 270.0 mg/mL, 652.0 mg/mL, 550.0 mg/mL

, Intra-arterial; Intravenous, Solution, Solution - Intra-arterial; Intravenous, Intravascular, Injection, solution, Injection, solution - Intravascular

excretory urography

, 320.0 mg/mL, 270.0 mg/mL, 652.0 mg/mL, 550.0 mg/mL

, Intra-arterial; Intravenous, Solution, Solution - Intra-arterial; Intravenous, Intravascular, Injection, solution, Injection, solution - Intravascular

Contrast Enhanced Computed Tomography (CT) Scanning

, 320.0 mg/mL, 270.0 mg/mL, 652.0 mg/mL, 550.0 mg/mL

, Intra-arterial; Intravenous, Solution, Solution - Intra-arterial; Intravenous, Intravascular, Injection, solution, Injection, solution - Intravascular

Arteriography

, 320.0 mg/mL, 270.0 mg/mL, 652.0 mg/mL, 550.0 mg/mL

, Intra-arterial; Intravenous, Solution, Solution - Intra-arterial; Intravenous, Intravascular, Injection, solution, Injection, solution - Intravascular

angiogram

, 320.0 mg/mL, 270.0 mg/mL, 652.0 mg/mL, 550.0 mg/mL

, Intra-arterial; Intravenous, Solution, Solution - Intra-arterial; Intravenous, Intravascular, Injection, solution, Injection, solution - Intravascular

left ventriculography

, 320.0 mg/mL, 270.0 mg/mL, 652.0 mg/mL, 550.0 mg/mL

, Intra-arterial; Intravenous, Solution, Solution - Intra-arterial; Intravenous, Intravascular, Injection, solution, Injection, solution - Intravascular

peripheral venography

, 320.0 mg/mL, 270.0 mg/mL, 652.0 mg/mL, 550.0 mg/mL

, Intra-arterial; Intravenous, Solution, Solution - Intra-arterial; Intravenous, Intravascular, Injection, solution, Injection, solution - Intravascular

selective coronary arteriography

, 320.0 mg/mL, 270.0 mg/mL, 652.0 mg/mL, 550.0 mg/mL

, Intra-arterial; Intravenous, Solution, Solution - Intra-arterial; Intravenous, Intravascular, Injection, solution, Injection, solution - Intravascular

Warnings

Visipaque 320 has two contraindications and should not be administered along with the ailments indicated in the following table.

Visipaque 320 Contraindications

Condition

Risk Level

Notes

intrathecal

Do Not Combine

laxative

Do Not Combine

There are 20 known major drug interactions with Visipaque 320.

Common Visipaque 320 Drug Interactions

Drug Name

Risk Level

Description

Aclidinium

Minor

Iodixanol may decrease the excretion rate of Aclidinium which could result in a higher serum level.

Acrivastine

Minor

Iodixanol may decrease the excretion rate of Acrivastine which could result in a higher serum level.

Albutrepenonacog alfa

Minor

Iodixanol may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.

Allylestrenol

Minor

Iodixanol may decrease the excretion rate of Allylestrenol which could result in a higher serum level.

Almasilate

Minor

Iodixanol may decrease the excretion rate of Almasilate which could result in a higher serum level.

Visipaque 320 Toxicity & Overdose Risk

Iodixanol has been found to be toxic to kidney cells. The effects of this toxicity may include cell death, reduced cellular energy, changes in calcium levels, and alterations in cell structure. These effects are thought to be caused by an increase in oxidative stress.

image of a doctor in a lab doing drug, clinical research

Visipaque 320 Novel Uses: Which Conditions Have a Clinical Trial Featuring Visipaque 320?

Currently, there are no active clinical trials assessing the potential of Visipaque 320 in Contrast Enhanced Computed Tomography (CT) Scanning, Peripheral Venography and Arteriography.

Condition

Clinical Trials

Trial Phases

Contrast Enhanced Computed Tomography (CT) Scanning

0 Actively Recruiting

excretory urography

0 Actively Recruiting

peripheral venography

0 Actively Recruiting

peripheral arteriography

0 Actively Recruiting

left ventriculography

0 Actively Recruiting

angiogram

0 Actively Recruiting

selective coronary arteriography

0 Actively Recruiting

Arteriography

0 Actively Recruiting

Arteriography

0 Actively Recruiting

Visipaque 320 Reviews: What are patients saying about Visipaque 320?

1.3

Patient Review

11/17/2007

Visipaque 320 for X-Rays Done for Diagnostic Purposes

I had a severe reaction to this medication which included itching in my lower legs for five days. I tried various remedies with no relief. Even now, ten days later, I'm still dealing with hives on other parts of my body.

1.3

Patient Review

10/28/2008

Visipaque 320 for X-Rays Done for Diagnostic Purposes

Within 20 seconds of the injection, I started feeling weird. My throat and face started swelling up (anaphylactic shock).

1.3

Patient Review

11/17/2007

Visipaque 320 for X-Rays Done for Diagnostic Purposes

I had a really severe reaction to this treatment. For days afterwards I was intensely itching my legs and nothing provided relief.

1.3

Patient Review

10/28/2008

Visipaque 320 for X-Rays Done for Diagnostic Purposes

Almost immediately after this was injected into my IV, I started to feel weird. My throat and face started swelling up (anaphylactic shock).

1

Patient Review

8/7/2014

Visipaque 320 for X-Ray Imaging of Heart & Great Vessels by Using Contrast

I was extremely dizzy, nauseous, and had a severe drop in blood pressure and headache after stents were placed. I also received an absurdly high bill for this treatment - $500 per 100ML dose! After doing some research, I found that most hospitals only pay $1 per ML for this medication. There are much better options out there than this one, especially for people with diabetes or kidney problems.

1

Patient Review

8/7/2014

Visipaque 320 for X-Ray Imaging of Heart & Great Vessels by Using Contrast

I had to be hospitalized after experiencing severe dizziness, nausea, and a drop in blood pressure following this treatment. I was also very surprised to see that each 100ml dose cost over $500. Iopamidol seems like a much better option, especially for people with diabetes or kidney issues.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about visipaque 320

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the difference between omnipaque and Visipaque?

"There are two types of iodinated contrast agents, Omnipaque and Visipaque, that are used for CT and CTA applications. Omnipaque is typically used for routine CT and low volume CTA studies, while Visipaque is used for high volume CTA and in patients whose EGFR is between 30 and 50ml/min."

Answered by AI

When is Visipaque used?

"Visipaque is a prescription medicine that is used as a contrast agent for CT scans or other radiologic examinations. It may be used alone or with other medications. Visipaque belongs to a class of drugs called iodinated contrast media, which are contrast media that have been treated with iodine."

Answered by AI

How much does Visipaque cost?

"What is the cost for 500 mL of Visipaque injectable solution (320 mg/mL)? The cost for 500 mL of Visipaque injectable solution (320 mg/mL) is around $567, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans."

Answered by AI

Is Visipaque safer than omnipaque?

"Visipaque had a big win in 2003 when a study in The New England Journal of Medicine found that the iso-osmolar agent was significantly safer than a low-osmolar agent (Omnipaque) in preventing contrast-induced nephropathy in coronary angiography patients."

Answered by AI